EUVIMEDEUVIMED entdecken
Open Access

Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway

Guangru Li, Ruiqing Liu, Zeyan Peng, Shengzheng Zhang, Runjia Sun, Ziwei Wang, Jing Li, Yang Gao, Yang Xu, Jianlin Cui, Jie Liu, Jie Yan und 7 weitere

Theranostics · 31.03.2025 · 15 (11) · 4989-5006

DOI: 10.7150/thno.107367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 31.03.2025. Verfasst von Guangru Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, School of Medicine, Nankai University; Department of Cardiology, Beichen Hospital, Nankai University, Tianjin, …. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, NF-E2-Related Factor 2, Ferroptosis, Caveolin 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesNF-E2-Related Factor 2FerroptosisCaveolin 1AnimalsMiceRatsMyocytes, CardiacSignal TransductionDiabetes Mellitus, ExperimentalMaleMice, KnockoutReactive Oxygen SpeciesMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

Caveolin-1Diabetic cardiomyopathyFerroptosisGCLCNRF2

Substanzen

NF-E2-Related Factor 2Caveolin 1Nfe2l2 protein, mouseReactive Oxygen SpeciesCav1 protein, mouse

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, School of Medicine, Nankai University; Department of Cardiology, Beichen Hospital, Nankai University, Tianjin, 300071, China.
  • School of Medical Technology, Tianjin Medical University, Tianjin, 300203, China.
  • The Third Central Hospital of Tianjin, 83 Jintang Road, Hedong District, Tianjin, 300170, China.
  • Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases.
  • Artificial Cell Engineering Technology Research Center, Tianjin, China.
  • Tianjin Institute of Hepatobiliary Disease, Tianjin, China.

Zitieren

APA

Li, G., Liu, R., Peng, Z., Zhang, S., Sun, R., Wang, Z., Li, J., Gao, Y., Xu, Y., Cui, J., Liu, J., Yan, J., Cao, L., Ren, S., Chu, Y., Feng, L., Yang, L., Shen, Y., & Qi, Z. (2025). Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway. Theranostics, 15(11), 4989-5006. https://doi.org/10.7150/thno.107367

Vancouver

Li G, Liu R, Peng Z, Zhang S, Sun R, Wang Z, et al. Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway. Theranostics. 2025;15(11):4989-5006. doi:10.7150/thno.107367

BibTeX
@article{Li2025,
  author = {Li, Guangru and Liu, Ruiqing and Peng, Zeyan and Zhang, Shengzheng and Sun, Runjia and Wang, Ziwei and Li, Jing and Gao, Yang and Xu, Yang and Cui, Jianlin and Liu, Jie and Yan, Jie and Cao, Lei and Ren, Shan and Chu, Yushun and Feng, Lifeng and Yang, Liang and Shen, Yanna and Qi, Zhi},
  title = {Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {4989--5006},
  doi = {10.7150/thno.107367}
}
Kostenlos starten →